CPA3 and chronic obstructive pulmonary disease: It is, however, noteworthy that, as for asthma (34, 44), CPA3 levels in COPD and IPF may be particularly elevated in the subcategory of patients that have a type 2 immunity and eosinophil signature (29, 45).